COVID-19 Research Project in the US with OmicsBox Support
Understanding the molecular differences that underlie the different COVID19 progression severity with Omic
Understanding the molecular differences that underlie the different COVID19 progression severity with Omic
BioBam Supported Project – with OmicsBox. Researchers: Dr. Abhishek Kumar, Computational Genome Biology Lab at Institute of Bioinformatics, Bangalore, India Project: The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pushed the entire world on a halt with the largest lockdown of our times. A total numbers of infected cases are
BioBam Supported Project – with OmicsBox. Researchers: Richard Lathe – Division of Infection Medicine, University of Edinburgh Medical School, Edinburgh, UK Project: In managing the COVID-19 pandemic there is an urgent need to understand why some people develop severe infection leading to hospitalization and mortality, whereas others are relatively unaffected.
BioBam Supported Project – with OmicsBox. Researchers: Pr. Sami Aifa from the Laboratory of Molecular and Cellular Screening Processes (LPCMC) from the Centre of Biotechnology of Sfax, Tunisia Dr. Amor Mosbah from the Laboratory of Biotechnology and Valorization of Bio-Geo-Ressources (LBVBGR) from the Superior Institute of Biotechnology of Sidi Thabet, Tunisia Dr. Salma Abdeljalil and Pr. Ali Gargouri from the
BioBam Supported Project – with OmicsBox. Researchers: Luis Fernando Saraiva Macedo Timmers – Coordinator – Univates, Brazil Rafael Andrade Caceres – UFCSPA, Brazil Leandro de Mattos Pereira, UFRJ, Brazil Fernando Ruggiero Bachega – UFCSPA, Brazil Marcia Ines Goettert – Univates, Brazil Luiz Augusto Basso – PUCRS, Brazil Project: Currently, a large amount of data is available regarding the new SARS-CoV-2